Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RORγ is a nuclear receptor and transcription factor that plays a critical role in immune regulation, metabolism, and circadian rhythm. It is a master regulator of Th17 cell differentiation and is implicated in the pathogenesis of autoimmune diseases. RORγ is also involved in the development of lymph nodes and Peyer’s patches, and regulates circadian genes. Due to its druggability, it is an emerging target for autoimmune diseases and cancer immunotherapy.
Agonism or inverse agonism of RORγ to modulate gene transcription related to immune responses, metabolism, and circadian rhythm.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic Acid Receptor-Related Orphan Receptor Gamma (RORγ).